ARYZTA AG
ARYZTA AG (ARZTY) Stock Competitors & Peer Comparison
See (ARZTY) competitors and their performances in Stock Market.
Peer Comparison Table: Packaged Foods Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ARZTY | $6.48 | +0.00% | 1.6B | 12.96 | $0.50 | N/A |
| NSRGY | $104.72 | +0.00% | 268.2B | 20.08 | $5.19 | +3.26% |
| NSRGF | $105.55 | +0.00% | 266B | 19.92 | $5.19 | +3.57% |
| DANOY | $17.39 | +0.00% | 55.8B | 25.49 | $0.68 | +2.72% |
| GPDNF | $85.82 | +0.00% | 55B | 25.35 | $3.36 | +2.86% |
| JBSAY | $13.81 | +3.06% | 30.6B | 6.94 | $1.99 | +7.26% |
| AJINF | $30.00 | +9.21% | 28.8B | 125.00 | $0.24 | +0.99% |
| ASBFF | $28.38 | +0.00% | 20B | 14.70 | $1.93 | +2.98% |
| ASBFY | $26.59 | +0.00% | 18.8B | 13.70 | $1.93 | +2.86% |
| JDEPF | $36.40 | -0.01% | 17.7B | 25.11 | $1.45 | +2.35% |
Stock Comparison
ARZTY vs NSRGY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NSRGY has a market cap of 268.2B. Regarding current trading prices, ARZTY is priced at $6.48, while NSRGY trades at $104.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NSRGY's P/E ratio is 20.08. In terms of profitability, ARZTY's ROE is +0.27%, compared to NSRGY's ROE of +0.29%. Regarding short-term risk, ARZTY is less volatile compared to NSRGY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NSRGY's competition here
ARZTY vs NSRGF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NSRGF has a market cap of 266B. Regarding current trading prices, ARZTY is priced at $6.48, while NSRGF trades at $105.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NSRGF's P/E ratio is 19.92. In terms of profitability, ARZTY's ROE is +0.27%, compared to NSRGF's ROE of +0.29%. Regarding short-term risk, ARZTY is less volatile compared to NSRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check NSRGF's competition here
ARZTY vs DANOY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, DANOY has a market cap of 55.8B. Regarding current trading prices, ARZTY is priced at $6.48, while DANOY trades at $17.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas DANOY's P/E ratio is 25.49. In terms of profitability, ARZTY's ROE is +0.27%, compared to DANOY's ROE of +0.11%. Regarding short-term risk, ARZTY is less volatile compared to DANOY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check DANOY's competition here
ARZTY vs GPDNF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GPDNF has a market cap of 55B. Regarding current trading prices, ARZTY is priced at $6.48, while GPDNF trades at $85.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GPDNF's P/E ratio is 25.35. In terms of profitability, ARZTY's ROE is +0.27%, compared to GPDNF's ROE of +0.11%. Regarding short-term risk, ARZTY and GPDNF have similar daily volatility (0.00).Check GPDNF's competition here
ARZTY vs JBSAY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, JBSAY has a market cap of 30.6B. Regarding current trading prices, ARZTY is priced at $6.48, while JBSAY trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas JBSAY's P/E ratio is 6.94. In terms of profitability, ARZTY's ROE is +0.27%, compared to JBSAY's ROE of +0.29%. Regarding short-term risk, ARZTY is less volatile compared to JBSAY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check JBSAY's competition here
ARZTY vs AJINF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, AJINF has a market cap of 28.8B. Regarding current trading prices, ARZTY is priced at $6.48, while AJINF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas AJINF's P/E ratio is 125.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to AJINF's ROE of +0.11%. Regarding short-term risk, ARZTY and AJINF have similar daily volatility (0.00).Check AJINF's competition here
ARZTY vs ASBFF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, ASBFF has a market cap of 20B. Regarding current trading prices, ARZTY is priced at $6.48, while ASBFF trades at $28.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas ASBFF's P/E ratio is 14.70. In terms of profitability, ARZTY's ROE is +0.27%, compared to ASBFF's ROE of +0.08%. Regarding short-term risk, ARZTY and ASBFF have similar daily volatility (0.00).Check ASBFF's competition here
ARZTY vs ASBFY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, ASBFY has a market cap of 18.8B. Regarding current trading prices, ARZTY is priced at $6.48, while ASBFY trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas ASBFY's P/E ratio is 13.70. In terms of profitability, ARZTY's ROE is +0.27%, compared to ASBFY's ROE of +0.09%. Regarding short-term risk, ARZTY is less volatile compared to ASBFY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check ASBFY's competition here
ARZTY vs JDEPF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, JDEPF has a market cap of 17.7B. Regarding current trading prices, ARZTY is priced at $6.48, while JDEPF trades at $36.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas JDEPF's P/E ratio is 25.11. In terms of profitability, ARZTY's ROE is +0.27%, compared to JDEPF's ROE of +0.06%. Regarding short-term risk, ARZTY and JDEPF have similar daily volatility (0.00).Check JDEPF's competition here
ARZTY vs GRBMF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GRBMF has a market cap of 17.2B. Regarding current trading prices, ARZTY is priced at $6.48, while GRBMF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GRBMF's P/E ratio is 26.67. In terms of profitability, ARZTY's ROE is +0.27%, compared to GRBMF's ROE of +0.09%. Regarding short-term risk, ARZTY and GRBMF have similar daily volatility (0.00).Check GRBMF's competition here
ARZTY vs WHGLY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, WHGLY has a market cap of 16.4B. Regarding current trading prices, ARZTY is priced at $6.48, while WHGLY trades at $25.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas WHGLY's P/E ratio is 10.14. In terms of profitability, ARZTY's ROE is +0.27%, compared to WHGLY's ROE of +0.15%. Regarding short-term risk, ARZTY is less volatile compared to WHGLY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check WHGLY's competition here
ARZTY vs BMBOY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, BMBOY has a market cap of 16.3B. Regarding current trading prices, ARZTY is priced at $6.48, while BMBOY trades at $15.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas BMBOY's P/E ratio is 24.80. In terms of profitability, ARZTY's ROE is +0.27%, compared to BMBOY's ROE of +0.09%. Regarding short-term risk, ARZTY and BMBOY have similar daily volatility (0.00).Check BMBOY's competition here
ARZTY vs AJINY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, AJINY has a market cap of 15.2B. Regarding current trading prices, ARZTY is priced at $6.48, while AJINY trades at $29.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas AJINY's P/E ratio is 118.89. In terms of profitability, ARZTY's ROE is +0.27%, compared to AJINY's ROE of +0.11%. Regarding short-term risk, ARZTY is less volatile compared to AJINY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check AJINY's competition here
ARZTY vs WHGRF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, WHGRF has a market cap of 14.8B. Regarding current trading prices, ARZTY is priced at $6.48, while WHGRF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas WHGRF's P/E ratio is 8.85. In terms of profitability, ARZTY's ROE is +0.27%, compared to WHGRF's ROE of +0.15%. Regarding short-term risk, ARZTY and WHGRF have similar daily volatility (0.00).Check WHGRF's competition here
ARZTY vs KRYAY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, KRYAY has a market cap of 13.8B. Regarding current trading prices, ARZTY is priced at $6.48, while KRYAY trades at $86.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas KRYAY's P/E ratio is 17.39. In terms of profitability, ARZTY's ROE is +0.27%, compared to KRYAY's ROE of +0.11%. Regarding short-term risk, ARZTY is less volatile compared to KRYAY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check KRYAY's competition here
ARZTY vs KRYAF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, KRYAF has a market cap of 13.5B. Regarding current trading prices, ARZTY is priced at $6.48, while KRYAF trades at $84.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas KRYAF's P/E ratio is 17.10. In terms of profitability, ARZTY's ROE is +0.27%, compared to KRYAF's ROE of +0.09%. Regarding short-term risk, ARZTY and KRYAF have similar daily volatility (0.00).Check KRYAF's competition here
ARZTY vs ORKLF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, ORKLF has a market cap of 13.5B. Regarding current trading prices, ARZTY is priced at $6.48, while ORKLF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas ORKLF's P/E ratio is 20.22. In terms of profitability, ARZTY's ROE is +0.27%, compared to ORKLF's ROE of +0.24%. Regarding short-term risk, ARZTY and ORKLF have similar daily volatility (0.00).Check ORKLF's competition here
ARZTY vs ORKLY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, ORKLY has a market cap of 13.3B. Regarding current trading prices, ARZTY is priced at $6.48, while ORKLY trades at $13.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas ORKLY's P/E ratio is 19.90. In terms of profitability, ARZTY's ROE is +0.27%, compared to ORKLY's ROE of +0.24%. Regarding short-term risk, ARZTY is less volatile compared to ORKLY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check ORKLY's competition here
ARZTY vs SAPIF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, SAPIF has a market cap of 12.4B. Regarding current trading prices, ARZTY is priced at $6.48, while SAPIF trades at $30.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas SAPIF's P/E ratio is 26.69. In terms of profitability, ARZTY's ROE is +0.27%, compared to SAPIF's ROE of +0.09%. Regarding short-term risk, ARZTY is less volatile compared to SAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check SAPIF's competition here
ARZTY vs SDPNF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, SDPNF has a market cap of 10.3B. Regarding current trading prices, ARZTY is priced at $6.48, while SDPNF trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas SDPNF's P/E ratio is 14.89. In terms of profitability, ARZTY's ROE is +0.27%, compared to SDPNF's ROE of +0.14%. Regarding short-term risk, ARZTY is less volatile compared to SDPNF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check SDPNF's competition here
ARZTY vs BRZL Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, BRZL has a market cap of 10.1B. Regarding current trading prices, ARZTY is priced at $6.48, while BRZL trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas BRZL's P/E ratio is N/A. In terms of profitability, ARZTY's ROE is +0.27%, compared to BRZL's ROE of +0.91%. Regarding short-term risk, ARZTY is less volatile compared to BRZL. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check BRZL's competition here
ARZTY vs LOTBY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, LOTBY has a market cap of 9.8B. Regarding current trading prices, ARZTY is priced at $6.48, while LOTBY trades at $120.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas LOTBY's P/E ratio is 51.92. In terms of profitability, ARZTY's ROE is +0.27%, compared to LOTBY's ROE of +0.21%. Regarding short-term risk, ARZTY and LOTBY have similar daily volatility (0.00).Check LOTBY's competition here
ARZTY vs TYCMY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TYCMY has a market cap of 9.5B. Regarding current trading prices, ARZTY is priced at $6.48, while TYCMY trades at $33.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TYCMY's P/E ratio is 15.95. In terms of profitability, ARZTY's ROE is +0.27%, compared to TYCMY's ROE of +0.31%. Regarding short-term risk, ARZTY is less volatile compared to TYCMY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TYCMY's competition here
ARZTY vs KIKOY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, KIKOY has a market cap of 9B. Regarding current trading prices, ARZTY is priced at $6.48, while KIKOY trades at $19.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas KIKOY's P/E ratio is 24.45. In terms of profitability, ARZTY's ROE is +0.27%, compared to KIKOY's ROE of +0.12%. Regarding short-term risk, ARZTY and KIKOY have similar daily volatility (0.00).Check KIKOY's competition here
ARZTY vs TTAZF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TTAZF has a market cap of 8.8B. Regarding current trading prices, ARZTY is priced at $6.48, while TTAZF trades at $7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TTAZF's P/E ratio is 77.60. In terms of profitability, ARZTY's ROE is +0.27%, compared to TTAZF's ROE of N/A. Regarding short-term risk, ARZTY and TTAZF have similar daily volatility (0.00).Check TTAZF's competition here
ARZTY vs CIADF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, CIADF has a market cap of 8.5B. Regarding current trading prices, ARZTY is priced at $6.48, while CIADF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas CIADF's P/E ratio is -220.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to CIADF's ROE of -0.01%. Regarding short-term risk, ARZTY and CIADF have similar daily volatility (0.00).Check CIADF's competition here
ARZTY vs CIADY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, CIADY has a market cap of 8.4B. Regarding current trading prices, ARZTY is priced at $6.48, while CIADY trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas CIADY's P/E ratio is -194.27. In terms of profitability, ARZTY's ROE is +0.27%, compared to CIADY's ROE of -0.01%. Regarding short-term risk, ARZTY is less volatile compared to CIADY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check CIADY's competition here
ARZTY vs KIKOF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, KIKOF has a market cap of 8.2B. Regarding current trading prices, ARZTY is priced at $6.48, while KIKOF trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas KIKOF's P/E ratio is 22.56. In terms of profitability, ARZTY's ROE is +0.27%, compared to KIKOF's ROE of +0.11%. Regarding short-term risk, ARZTY and KIKOF have similar daily volatility (0.00).Check KIKOF's competition here
ARZTY vs WWNTY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, WWNTY has a market cap of 7.5B. Regarding current trading prices, ARZTY is priced at $6.48, while WWNTY trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas WWNTY's P/E ratio is 12.35. In terms of profitability, ARZTY's ROE is +0.27%, compared to WWNTY's ROE of +0.30%. Regarding short-term risk, ARZTY and WWNTY have similar daily volatility (0.00).Check WWNTY's competition here
ARZTY vs TSUKY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TSUKY has a market cap of 7.4B. Regarding current trading prices, ARZTY is priced at $6.48, while TSUKY trades at $77.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TSUKY's P/E ratio is 18.46. In terms of profitability, ARZTY's ROE is +0.27%, compared to TSUKY's ROE of +0.13%. Regarding short-term risk, ARZTY is less volatile compared to TSUKY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TSUKY's competition here
ARZTY vs TCYMF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TCYMF has a market cap of 7.3B. Regarding current trading prices, ARZTY is priced at $6.48, while TCYMF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TCYMF's P/E ratio is 13.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to TCYMF's ROE of +0.31%. Regarding short-term risk, ARZTY and TCYMF have similar daily volatility (0.00).Check TCYMF's competition here
ARZTY vs ARHUF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, ARHUF has a market cap of 7.3B. Regarding current trading prices, ARZTY is priced at $6.48, while ARHUF trades at $27.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas ARHUF's P/E ratio is 19.16. In terms of profitability, ARZTY's ROE is +0.27%, compared to ARHUF's ROE of +0.18%. Regarding short-term risk, ARZTY and ARHUF have similar daily volatility (0.00).Check ARHUF's competition here
ARZTY vs TSUKF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TSUKF has a market cap of 6.9B. Regarding current trading prices, ARZTY is priced at $6.48, while TSUKF trades at $70.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TSUKF's P/E ratio is 17.59. In terms of profitability, ARZTY's ROE is +0.27%, compared to TSUKF's ROE of +0.13%. Regarding short-term risk, ARZTY and TSUKF have similar daily volatility (0.00).Check TSUKF's competition here
ARZTY vs MEJHY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, MEJHY has a market cap of 6.8B. Regarding current trading prices, ARZTY is priced at $6.48, while MEJHY trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas MEJHY's P/E ratio is 23.15. In terms of profitability, ARZTY's ROE is +0.27%, compared to MEJHY's ROE of +0.06%. Regarding short-term risk, ARZTY and MEJHY have similar daily volatility (0.00).Check MEJHY's competition here
ARZTY vs WWNTF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, WWNTF has a market cap of 6.6B. Regarding current trading prices, ARZTY is priced at $6.48, while WWNTF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas WWNTF's P/E ratio is 11.20. In terms of profitability, ARZTY's ROE is +0.27%, compared to WWNTF's ROE of +0.30%. Regarding short-term risk, ARZTY and WWNTF have similar daily volatility (0.00).Check WWNTF's competition here
ARZTY vs DLLFF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, DLLFF has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $6.48, while DLLFF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas DLLFF's P/E ratio is 14.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to DLLFF's ROE of N/A. Regarding short-term risk, ARZTY and DLLFF have similar daily volatility (0.00).Check DLLFF's competition here
ARZTY vs GPAGF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GPAGF has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $6.48, while GPAGF trades at $18.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GPAGF's P/E ratio is 12.05. In terms of profitability, ARZTY's ROE is +0.27%, compared to GPAGF's ROE of +0.23%. Regarding short-term risk, ARZTY and GPAGF have similar daily volatility (0.00).Check GPAGF's competition here
ARZTY vs GCHOY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GCHOY has a market cap of 6.5B. Regarding current trading prices, ARZTY is priced at $6.48, while GCHOY trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GCHOY's P/E ratio is 27.31. In terms of profitability, ARZTY's ROE is +0.27%, compared to GCHOY's ROE of +0.16%. Regarding short-term risk, ARZTY is less volatile compared to GCHOY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check GCHOY's competition here
ARZTY vs NFPDF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NFPDF has a market cap of 6.3B. Regarding current trading prices, ARZTY is priced at $6.48, while NFPDF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NFPDF's P/E ratio is 20.39. In terms of profitability, ARZTY's ROE is +0.27%, compared to NFPDF's ROE of +0.14%. Regarding short-term risk, ARZTY and NFPDF have similar daily volatility (0.00).Check NFPDF's competition here
ARZTY vs MEJHF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, MEJHF has a market cap of 6.2B. Regarding current trading prices, ARZTY is priced at $6.48, while MEJHF trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas MEJHF's P/E ratio is 19.34. In terms of profitability, ARZTY's ROE is +0.27%, compared to MEJHF's ROE of +0.06%. Regarding short-term risk, ARZTY is less volatile compared to MEJHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check MEJHF's competition here
ARZTY vs SGLJF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, SGLJF has a market cap of 6.2B. Regarding current trading prices, ARZTY is priced at $6.48, while SGLJF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas SGLJF's P/E ratio is 22.58. In terms of profitability, ARZTY's ROE is +0.27%, compared to SGLJF's ROE of +0.21%. Regarding short-term risk, ARZTY and SGLJF have similar daily volatility (0.00).Check SGLJF's competition here
ARZTY vs PIFFY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, PIFFY has a market cap of 5.7B. Regarding current trading prices, ARZTY is priced at $6.48, while PIFFY trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas PIFFY's P/E ratio is 16.15. In terms of profitability, ARZTY's ROE is +0.27%, compared to PIFFY's ROE of +0.13%. Regarding short-term risk, ARZTY and PIFFY have similar daily volatility (0.00).Check PIFFY's competition here
ARZTY vs SMPFF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, SMPFF has a market cap of 5.2B. Regarding current trading prices, ARZTY is priced at $6.48, while SMPFF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas SMPFF's P/E ratio is 13.38. In terms of profitability, ARZTY's ROE is +0.27%, compared to SMPFF's ROE of +0.24%. Regarding short-term risk, ARZTY and SMPFF have similar daily volatility (0.00).Check SMPFF's competition here
ARZTY vs EMLZF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, EMLZF has a market cap of 5.2B. Regarding current trading prices, ARZTY is priced at $6.48, while EMLZF trades at $969.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas EMLZF's P/E ratio is 18.94. In terms of profitability, ARZTY's ROE is +0.27%, compared to EMLZF's ROE of +0.22%. Regarding short-term risk, ARZTY and EMLZF have similar daily volatility (0.00).Check EMLZF's competition here
ARZTY vs TATYY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TATYY has a market cap of 5.1B. Regarding current trading prices, ARZTY is priced at $6.48, while TATYY trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TATYY's P/E ratio is 59.31. In terms of profitability, ARZTY's ROE is +0.27%, compared to TATYY's ROE of +0.02%. Regarding short-term risk, ARZTY is less volatile compared to TATYY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check TATYY's competition here
ARZTY vs GLAPY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GLAPY has a market cap of 5B. Regarding current trading prices, ARZTY is priced at $6.48, while GLAPY trades at $99.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GLAPY's P/E ratio is 41.06. In terms of profitability, ARZTY's ROE is +0.27%, compared to GLAPY's ROE of +0.06%. Regarding short-term risk, ARZTY and GLAPY have similar daily volatility (0.00).Check GLAPY's competition here
ARZTY vs GLAPF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GLAPF has a market cap of 4.8B. Regarding current trading prices, ARZTY is priced at $6.48, while GLAPF trades at $19.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GLAPF's P/E ratio is 42.53. In terms of profitability, ARZTY's ROE is +0.27%, compared to GLAPF's ROE of +0.09%. Regarding short-term risk, ARZTY and GLAPF have similar daily volatility (0.00).Check GLAPF's competition here
ARZTY vs IOIOF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, IOIOF has a market cap of 4.8B. Regarding current trading prices, ARZTY is priced at $6.48, while IOIOF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas IOIOF's P/E ratio is 12.64. In terms of profitability, ARZTY's ROE is +0.27%, compared to IOIOF's ROE of +0.10%. Regarding short-term risk, ARZTY and IOIOF have similar daily volatility (0.00).Check IOIOF's competition here
ARZTY vs ACOPF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, ACOPF has a market cap of 4.7B. Regarding current trading prices, ARZTY is priced at $6.48, while ACOPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas ACOPF's P/E ratio is 38.44. In terms of profitability, ARZTY's ROE is +0.27%, compared to ACOPF's ROE of +0.16%. Regarding short-term risk, ARZTY and ACOPF have similar daily volatility (0.00).Check ACOPF's competition here
ARZTY vs CHFLF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, CHFLF has a market cap of 4.5B. Regarding current trading prices, ARZTY is priced at $6.48, while CHFLF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas CHFLF's P/E ratio is 12.38. In terms of profitability, ARZTY's ROE is +0.27%, compared to CHFLF's ROE of +0.10%. Regarding short-term risk, ARZTY and CHFLF have similar daily volatility (0.00).Check CHFLF's competition here
ARZTY vs PIFMF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, PIFMF has a market cap of 4.4B. Regarding current trading prices, ARZTY is priced at $6.48, while PIFMF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas PIFMF's P/E ratio is 10.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to PIFMF's ROE of +0.11%. Regarding short-term risk, ARZTY and PIFMF have similar daily volatility (0.00).Check PIFMF's competition here
ARZTY vs NHFOF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NHFOF has a market cap of 4.3B. Regarding current trading prices, ARZTY is priced at $6.48, while NHFOF trades at $44.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NHFOF's P/E ratio is 25.28. In terms of profitability, ARZTY's ROE is +0.27%, compared to NHFOF's ROE of +0.06%. Regarding short-term risk, ARZTY and NHFOF have similar daily volatility (0.00).Check NHFOF's competition here
ARZTY vs CFEIY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, CFEIY has a market cap of 4.2B. Regarding current trading prices, ARZTY is priced at $6.48, while CFEIY trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas CFEIY's P/E ratio is 11.10. In terms of profitability, ARZTY's ROE is +0.27%, compared to CFEIY's ROE of +0.10%. Regarding short-term risk, ARZTY and CFEIY have similar daily volatility (0.00).Check CFEIY's competition here
ARZTY vs NIPMY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NIPMY has a market cap of 4B. Regarding current trading prices, ARZTY is priced at $6.48, while NIPMY trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NIPMY's P/E ratio is 20.39. In terms of profitability, ARZTY's ROE is +0.27%, compared to NIPMY's ROE of +0.06%. Regarding short-term risk, ARZTY and NIPMY have similar daily volatility (0.00).Check NIPMY's competition here
ARZTY vs NSLYF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NSLYF has a market cap of 4B. Regarding current trading prices, ARZTY is priced at $6.48, while NSLYF trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NSLYF's P/E ratio is 37.13. In terms of profitability, ARZTY's ROE is +0.27%, compared to NSLYF's ROE of +0.74%. Regarding short-term risk, ARZTY and NSLYF have similar daily volatility (0.00).Check NSLYF's competition here
ARZTY vs PIFMY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, PIFMY has a market cap of 3.6B. Regarding current trading prices, ARZTY is priced at $6.48, while PIFMY trades at $20.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas PIFMY's P/E ratio is 7.76. In terms of profitability, ARZTY's ROE is +0.27%, compared to PIFMY's ROE of +0.11%. Regarding short-term risk, ARZTY and PIFMY have similar daily volatility (0.00).Check PIFMY's competition here
ARZTY vs FPAFY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, FPAFY has a market cap of 3.6B. Regarding current trading prices, ARZTY is priced at $6.48, while FPAFY trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas FPAFY's P/E ratio is 4.99. In terms of profitability, ARZTY's ROE is +0.27%, compared to FPAFY's ROE of +0.17%. Regarding short-term risk, ARZTY is less volatile compared to FPAFY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check FPAFY's competition here
ARZTY vs YMZBY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, YMZBY has a market cap of 3.6B. Regarding current trading prices, ARZTY is priced at $6.48, while YMZBY trades at $180.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas YMZBY's P/E ratio is 14.08. In terms of profitability, ARZTY's ROE is +0.27%, compared to YMZBY's ROE of +0.10%. Regarding short-term risk, ARZTY and YMZBY have similar daily volatility (0.00).Check YMZBY's competition here
ARZTY vs FPAFF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, FPAFF has a market cap of 3.5B. Regarding current trading prices, ARZTY is priced at $6.48, while FPAFF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas FPAFF's P/E ratio is 4.88. In terms of profitability, ARZTY's ROE is +0.27%, compared to FPAFF's ROE of +0.17%. Regarding short-term risk, ARZTY and FPAFF have similar daily volatility (0.00).Check FPAFF's competition here
ARZTY vs CRWKF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, CRWKF has a market cap of 3.4B. Regarding current trading prices, ARZTY is priced at $6.48, while CRWKF trades at $63.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas CRWKF's P/E ratio is 23.79. In terms of profitability, ARZTY's ROE is +0.27%, compared to CRWKF's ROE of +0.15%. Regarding short-term risk, ARZTY and CRWKF have similar daily volatility (0.00).Check CRWKF's competition here
ARZTY vs PRBZF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, PRBZF has a market cap of 3.4B. Regarding current trading prices, ARZTY is priced at $6.48, while PRBZF trades at $76.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas PRBZF's P/E ratio is 70.69. In terms of profitability, ARZTY's ROE is +0.27%, compared to PRBZF's ROE of +0.04%. Regarding short-term risk, ARZTY and PRBZF have similar daily volatility (0.00).Check PRBZF's competition here
ARZTY vs NSFMF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NSFMF has a market cap of 3.3B. Regarding current trading prices, ARZTY is priced at $6.48, while NSFMF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NSFMF's P/E ratio is 14.20. In terms of profitability, ARZTY's ROE is +0.27%, compared to NSFMF's ROE of +0.05%. Regarding short-term risk, ARZTY and NSFMF have similar daily volatility (0.00).Check NSFMF's competition here
ARZTY vs EBRPF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, EBRPF has a market cap of 3.3B. Regarding current trading prices, ARZTY is priced at $6.48, while EBRPF trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas EBRPF's P/E ratio is 14.19. In terms of profitability, ARZTY's ROE is +0.27%, compared to EBRPF's ROE of +0.09%. Regarding short-term risk, ARZTY and EBRPF have similar daily volatility (0.00).Check EBRPF's competition here
ARZTY vs TBLMF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TBLMF has a market cap of 3.2B. Regarding current trading prices, ARZTY is priced at $6.48, while TBLMF trades at $20.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TBLMF's P/E ratio is 12.97. In terms of profitability, ARZTY's ROE is +0.27%, compared to TBLMF's ROE of +0.21%. Regarding short-term risk, ARZTY and TBLMF have similar daily volatility (0.00).Check TBLMF's competition here
ARZTY vs LYSFF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, LYSFF has a market cap of 3.2B. Regarding current trading prices, ARZTY is priced at $6.48, while LYSFF trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas LYSFF's P/E ratio is 17.10. In terms of profitability, ARZTY's ROE is +0.27%, compared to LYSFF's ROE of +0.09%. Regarding short-term risk, ARZTY and LYSFF have similar daily volatility (0.00).Check LYSFF's competition here
ARZTY vs LYSFY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, LYSFY has a market cap of 3.1B. Regarding current trading prices, ARZTY is priced at $6.48, while LYSFY trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas LYSFY's P/E ratio is 16.94. In terms of profitability, ARZTY's ROE is +0.27%, compared to LYSFY's ROE of +0.09%. Regarding short-term risk, ARZTY and LYSFY have similar daily volatility (0.00).Check LYSFY's competition here
ARZTY vs NCHEY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NCHEY has a market cap of 3.1B. Regarding current trading prices, ARZTY is priced at $6.48, while NCHEY trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NCHEY's P/E ratio is 18.06. In terms of profitability, ARZTY's ROE is +0.27%, compared to NCHEY's ROE of +0.10%. Regarding short-term risk, ARZTY and NCHEY have similar daily volatility (0.00).Check NCHEY's competition here
ARZTY vs MRRTY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, MRRTY has a market cap of 2.9B. Regarding current trading prices, ARZTY is priced at $6.48, while MRRTY trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas MRRTY's P/E ratio is 11.03. In terms of profitability, ARZTY's ROE is +0.27%, compared to MRRTY's ROE of +0.82%. Regarding short-term risk, ARZTY is less volatile compared to MRRTY. This indicates potentially lower risk in terms of short-term price fluctuations for ARZTY.Check MRRTY's competition here
ARZTY vs FSRCY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, FSRCY has a market cap of 2.9B. Regarding current trading prices, ARZTY is priced at $6.48, while FSRCY trades at $184.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas FSRCY's P/E ratio is 9.81. In terms of profitability, ARZTY's ROE is +0.27%, compared to FSRCY's ROE of +0.21%. Regarding short-term risk, ARZTY and FSRCY have similar daily volatility (0.00).Check FSRCY's competition here
ARZTY vs CBCFF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, CBCFF has a market cap of 2.8B. Regarding current trading prices, ARZTY is priced at $6.48, while CBCFF trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas CBCFF's P/E ratio is 21.90. In terms of profitability, ARZTY's ROE is +0.27%, compared to CBCFF's ROE of +0.08%. Regarding short-term risk, ARZTY and CBCFF have similar daily volatility (0.00).Check CBCFF's competition here
ARZTY vs FTROF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, FTROF has a market cap of 2.8B. Regarding current trading prices, ARZTY is priced at $6.48, while FTROF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas FTROF's P/E ratio is 9.47. In terms of profitability, ARZTY's ROE is +0.27%, compared to FTROF's ROE of +0.21%. Regarding short-term risk, ARZTY and FTROF have similar daily volatility (0.00).Check FTROF's competition here
ARZTY vs EBRPY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, EBRPY has a market cap of 2.8B. Regarding current trading prices, ARZTY is priced at $6.48, while EBRPY trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas EBRPY's P/E ratio is 20.34. In terms of profitability, ARZTY's ROE is +0.27%, compared to EBRPY's ROE of +0.06%. Regarding short-term risk, ARZTY and EBRPY have similar daily volatility (0.00).Check EBRPY's competition here
ARZTY vs UVRBF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, UVRBF has a market cap of 2.5B. Regarding current trading prices, ARZTY is priced at $6.48, while UVRBF trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas UVRBF's P/E ratio is 11.80. In terms of profitability, ARZTY's ROE is +0.27%, compared to UVRBF's ROE of +0.10%. Regarding short-term risk, ARZTY and UVRBF have similar daily volatility (0.00).Check UVRBF's competition here
ARZTY vs MLFNF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, MLFNF has a market cap of 2.5B. Regarding current trading prices, ARZTY is priced at $6.48, while MLFNF trades at $20.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas MLFNF's P/E ratio is 17.70. In terms of profitability, ARZTY's ROE is +0.27%, compared to MLFNF's ROE of +0.13%. Regarding short-term risk, ARZTY and MLFNF have similar daily volatility (0.00).Check MLFNF's competition here
ARZTY vs TATYF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TATYF has a market cap of 2.4B. Regarding current trading prices, ARZTY is priced at $6.48, while TATYF trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TATYF's P/E ratio is 61.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to TATYF's ROE of +0.02%. Regarding short-term risk, ARZTY and TATYF have similar daily volatility (0.00).Check TATYF's competition here
ARZTY vs CLBEY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, CLBEY has a market cap of 2.4B. Regarding current trading prices, ARZTY is priced at $6.48, while CLBEY trades at $4.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas CLBEY's P/E ratio is 22.64. In terms of profitability, ARZTY's ROE is +0.27%, compared to CLBEY's ROE of +0.08%. Regarding short-term risk, ARZTY and CLBEY have similar daily volatility (0.00).Check CLBEY's competition here
ARZTY vs PRRFY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, PRRFY has a market cap of 2.4B. Regarding current trading prices, ARZTY is priced at $6.48, while PRRFY trades at $12.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas PRRFY's P/E ratio is 13.74. In terms of profitability, ARZTY's ROE is +0.27%, compared to PRRFY's ROE of +0.15%. Regarding short-term risk, ARZTY and PRRFY have similar daily volatility (0.00).Check PRRFY's competition here
ARZTY vs SUEZF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, SUEZF has a market cap of 2.4B. Regarding current trading prices, ARZTY is priced at $6.48, while SUEZF trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas SUEZF's P/E ratio is -10.50. In terms of profitability, ARZTY's ROE is +0.27%, compared to SUEZF's ROE of -0.06%. Regarding short-term risk, ARZTY and SUEZF have similar daily volatility (0.00).Check SUEZF's competition here
ARZTY vs SUEZY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, SUEZY has a market cap of 2.3B. Regarding current trading prices, ARZTY is priced at $6.48, while SUEZY trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas SUEZY's P/E ratio is -10.27. In terms of profitability, ARZTY's ROE is +0.27%, compared to SUEZY's ROE of -0.06%. Regarding short-term risk, ARZTY and SUEZY have similar daily volatility (0.00).Check SUEZY's competition here
ARZTY vs NISUY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, NISUY has a market cap of 2.2B. Regarding current trading prices, ARZTY is priced at $6.48, while NISUY trades at $72.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas NISUY's P/E ratio is 12.71. In terms of profitability, ARZTY's ROE is +0.27%, compared to NISUY's ROE of +0.10%. Regarding short-term risk, ARZTY and NISUY have similar daily volatility (0.00).Check NISUY's competition here
ARZTY vs UVRBY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, UVRBY has a market cap of 2.2B. Regarding current trading prices, ARZTY is priced at $6.48, while UVRBY trades at $10.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas UVRBY's P/E ratio is 10.78. In terms of profitability, ARZTY's ROE is +0.27%, compared to UVRBY's ROE of +0.10%. Regarding short-term risk, ARZTY and UVRBY have similar daily volatility (0.00).Check UVRBY's competition here
ARZTY vs PFODF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, PFODF has a market cap of 2.1B. Regarding current trading prices, ARZTY is priced at $6.48, while PFODF trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas PFODF's P/E ratio is 12.40. In terms of profitability, ARZTY's ROE is +0.27%, compared to PFODF's ROE of +0.11%. Regarding short-term risk, ARZTY and PFODF have similar daily volatility (0.00).Check PFODF's competition here
ARZTY vs GRPBF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GRPBF has a market cap of 2.1B. Regarding current trading prices, ARZTY is priced at $6.48, while GRPBF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GRPBF's P/E ratio is N/A. In terms of profitability, ARZTY's ROE is +0.27%, compared to GRPBF's ROE of N/A. Regarding short-term risk, ARZTY and GRPBF have similar daily volatility (0.00).Check GRPBF's competition here
ARZTY vs ARZTF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, ARZTF has a market cap of 1.9B. Regarding current trading prices, ARZTY is priced at $6.48, while ARZTF trades at $62.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas ARZTF's P/E ratio is 522.33. In terms of profitability, ARZTY's ROE is +0.27%, compared to ARZTF's ROE of +0.23%. Regarding short-term risk, ARZTY and ARZTF have similar daily volatility (0.00).Check ARZTF's competition here
ARZTY vs TUFBY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TUFBY has a market cap of 1.8B. Regarding current trading prices, ARZTY is priced at $6.48, while TUFBY trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TUFBY's P/E ratio is 12.05. In terms of profitability, ARZTY's ROE is +0.27%, compared to TUFBY's ROE of +0.10%. Regarding short-term risk, ARZTY and TUFBY have similar daily volatility (0.00).Check TUFBY's competition here
ARZTY vs HOFJF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, HOFJF has a market cap of 1.8B. Regarding current trading prices, ARZTY is priced at $6.48, while HOFJF trades at $19.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas HOFJF's P/E ratio is 23.90. In terms of profitability, ARZTY's ROE is +0.27%, compared to HOFJF's ROE of +0.04%. Regarding short-term risk, ARZTY and HOFJF have similar daily volatility (0.00).Check HOFJF's competition here
ARZTY vs GNCGF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GNCGF has a market cap of 1.8B. Regarding current trading prices, ARZTY is priced at $6.48, while GNCGF trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GNCGF's P/E ratio is 24.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to GNCGF's ROE of +0.12%. Regarding short-term risk, ARZTY and GNCGF have similar daily volatility (0.00).Check GNCGF's competition here
ARZTY vs TBLMY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TBLMY has a market cap of 1.7B. Regarding current trading prices, ARZTY is priced at $6.48, while TBLMY trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TBLMY's P/E ratio is 12.02. In terms of profitability, ARZTY's ROE is +0.27%, compared to TBLMY's ROE of +0.17%. Regarding short-term risk, ARZTY and TBLMY have similar daily volatility (0.00).Check TBLMY's competition here
ARZTY vs AVSFY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, AVSFY has a market cap of 1.7B. Regarding current trading prices, ARZTY is priced at $6.48, while AVSFY trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas AVSFY's P/E ratio is 12.32. In terms of profitability, ARZTY's ROE is +0.27%, compared to AVSFY's ROE of +0.47%. Regarding short-term risk, ARZTY and AVSFY have similar daily volatility (0.00).Check AVSFY's competition here
ARZTY vs YNNHF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, YNNHF has a market cap of 1.6B. Regarding current trading prices, ARZTY is priced at $6.48, while YNNHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas YNNHF's P/E ratio is 15.45. In terms of profitability, ARZTY's ROE is +0.27%, compared to YNNHF's ROE of +0.16%. Regarding short-term risk, ARZTY and YNNHF have similar daily volatility (0.00).Check YNNHF's competition here
ARZTY vs GUZOF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GUZOF has a market cap of 1.6B. Regarding current trading prices, ARZTY is priced at $6.48, while GUZOF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GUZOF's P/E ratio is 17.82. In terms of profitability, ARZTY's ROE is +0.27%, compared to GUZOF's ROE of +0.23%. Regarding short-term risk, ARZTY and GUZOF have similar daily volatility (0.00).Check GUZOF's competition here
ARZTY vs FNEVY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, FNEVY has a market cap of 1.5B. Regarding current trading prices, ARZTY is priced at $6.48, while FNEVY trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas FNEVY's P/E ratio is 13.00. In terms of profitability, ARZTY's ROE is +0.27%, compared to FNEVY's ROE of +0.05%. Regarding short-term risk, ARZTY and FNEVY have similar daily volatility (0.00).Check FNEVY's competition here
ARZTY vs FNEVF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, FNEVF has a market cap of 1.5B. Regarding current trading prices, ARZTY is priced at $6.48, while FNEVF trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas FNEVF's P/E ratio is 12.75. In terms of profitability, ARZTY's ROE is +0.27%, compared to FNEVF's ROE of +0.05%. Regarding short-term risk, ARZTY and FNEVF have similar daily volatility (0.00).Check FNEVF's competition here
ARZTY vs GNCGY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GNCGY has a market cap of 1.4B. Regarding current trading prices, ARZTY is priced at $6.48, while GNCGY trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GNCGY's P/E ratio is 18.84. In terms of profitability, ARZTY's ROE is +0.27%, compared to GNCGY's ROE of +0.12%. Regarding short-term risk, ARZTY and GNCGY have similar daily volatility (0.00).Check GNCGY's competition here
ARZTY vs HLFGY Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, HLFGY has a market cap of 1.4B. Regarding current trading prices, ARZTY is priced at $6.48, while HLFGY trades at $15.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas HLFGY's P/E ratio is 24.16. In terms of profitability, ARZTY's ROE is +0.27%, compared to HLFGY's ROE of +0.14%. Regarding short-term risk, ARZTY and HLFGY have similar daily volatility (0.00).Check HLFGY's competition here
ARZTY vs TUFUF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, TUFUF has a market cap of 1.1B. Regarding current trading prices, ARZTY is priced at $6.48, while TUFUF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas TUFUF's P/E ratio is 7.31. In terms of profitability, ARZTY's ROE is +0.27%, compared to TUFUF's ROE of +0.10%. Regarding short-term risk, ARZTY and TUFUF have similar daily volatility (0.00).Check TUFUF's competition here
ARZTY vs AKEJF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, AKEJF has a market cap of 1.1B. Regarding current trading prices, ARZTY is priced at $6.48, while AKEJF trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas AKEJF's P/E ratio is 16.59. In terms of profitability, ARZTY's ROE is +0.27%, compared to AKEJF's ROE of +0.05%. Regarding short-term risk, ARZTY and AKEJF have similar daily volatility (0.00).Check AKEJF's competition here
ARZTY vs JWLLF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, JWLLF has a market cap of 1.1B. Regarding current trading prices, ARZTY is priced at $6.48, while JWLLF trades at $25.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas JWLLF's P/E ratio is 24.38. In terms of profitability, ARZTY's ROE is +0.27%, compared to JWLLF's ROE of +0.13%. Regarding short-term risk, ARZTY and JWLLF have similar daily volatility (0.00).Check JWLLF's competition here
ARZTY vs GBFBF Comparison February 2026
ARZTY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARZTY stands at 1.6B. In comparison, GBFBF has a market cap of 1.1B. Regarding current trading prices, ARZTY is priced at $6.48, while GBFBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARZTY currently has a P/E ratio of 12.96, whereas GBFBF's P/E ratio is 12.38. In terms of profitability, ARZTY's ROE is +0.27%, compared to GBFBF's ROE of N/A. Regarding short-term risk, ARZTY and GBFBF have similar daily volatility (0.00).Check GBFBF's competition here